These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34653273)

  • 1. Dose identification of triamcinolone acetonide for noninvasive pre-corneal administration in the treatment of posterior uveitis using a rapid, sensitive HPLC method with photodiode-array detector.
    Khan MS; Ravi PR; Mullapudi TVR
    Biomed Chromatogr; 2022 Feb; 36(2):e5264. PubMed ID: 34653273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery.
    Shareef Khan M; Rao Ravi P; Shrikant Dhavan D
    Int J Pharm; 2023 Nov; 647():123530. PubMed ID: 37858638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, optimization, in vitro and in vivo evaluation of triamcinolone acetonide nanocrystals loaded in situ gel for topical ocular delivery.
    Khan MS; Ravi PR; Dhavan DS
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113539. PubMed ID: 37742362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide.
    Zacharias LC; Lin T; Migon R; Ghosn C; Orilla W; Feldmann B; Ruiz G; Li Y; Burke J; Kuppermann BD
    Retina; 2013 Mar; 33(3):522-31. PubMed ID: 22990317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer Nanoparticles with 2-HP-β-Cyclodextrin for Enhanced Retention of Uptake into HCE-T Cells.
    Qin Z; Li B; Deng Q; Wen Y; Feng S; Duan C; Zhao B; Li H; Gao Y; Ban J
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring triamcinolone acetonide in aqueous humor by gas chromatography-electron-capture negative-ion mass spectrometry.
    Chu KO; Ho TC; Chiang WY; Wang CC; Lam DS; Pang CP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):199-204. PubMed ID: 17097356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of triamcinolone acetonide in silicone oil and aqueous humor of vitrectomized rabbits' eyes: Application for a pharmacokinetic study with intravitreal triamcinolone acetonide injections (Kenalog® 40).
    Fernandes-Cunha GM; Saliba JB; Siqueira RC; Jorge R; Silva-Cunha A
    J Pharm Biomed Anal; 2014 Feb; 89():24-7. PubMed ID: 24252721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of triamcinolone acetonide in ocular tissues after intravitreal injection to rabbit using liquid chromatography-tandem mass spectrometry.
    Zhang SQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):548-52. PubMed ID: 21296037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY; Davis JL; Salmon JH; Gilger BC
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice.
    Chen H; Sun S; Li J; Du W; Zhao C; Hou J; Xu Y; Cheng L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2178-85. PubMed ID: 23449717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes.
    Mason JO; Somaiya MD; Singh RJ
    Retina; 2004 Dec; 24(6):900-4. PubMed ID: 15579987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
    Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
    Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rufloxacin eyedrops: effect of different formulations on ocular pharmacokinetics in rabbits.
    Burgalassi S; Cappello B; Chetoni P; Iervolino M; Monti D; Saettone MF
    Eur J Ophthalmol; 2006; 16(2):311-7. PubMed ID: 16703552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Three Corticosteroids in the Biologic Matrix of Vitreous Humor by HPLC-tandem Mass Spectrometry: Method Development and Validation.
    Prieto E; Vispe E; Otín-Mallada S; Garcia-Martin E; Polo-Llorens V; Fraile JM; Pablo LE; Mayoral JA
    Curr Eye Res; 2017 Feb; 42(2):244-251. PubMed ID: 27400236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
    Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
    Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.